At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Mar 15, 2026 at 20:00 ET
CEO Claire Mazumdar and President Ryan Cohlhepp of Bicara Therapeutics (BCAX) exercised stock options and sold shares in a coordinated cluster over four days, generating $302,422 in open-market sales. The transactions represent modest insider selling following derivative exercises, with total proceeds under 0.1% of the company's $1.0B market cap.
- CEO Claire Mazumdar sold 15,000 shares for $282,366 across three days (March 18–20), following full option exercises.
- President Ryan Cohlhepp sold 8,000 shares for $157,257 on March 16 after exercising options.
- All sales were open-market transactions (code S) preceded by derivative exercises (code M).
- Total cash proceeds from selling activity: $302,422 (CEO: $282,366, President: $157,257).
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access